Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | GFER | P55789 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | HTR7 | P34969 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1129918 | 0.99 | CYP1A2 (0.65) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL1129828 | 0.99 | CYP1A2 (0.65) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL1130354 | 0.97 | CYP1A2 (0.67) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL6141647 | 0.86 | CYP1A2 (0.83) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| Bromide SCHEMBL5084016 | 0.85 | CYP1A2 (0.80) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL15501213 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL11339285 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL2208304 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL19614388 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL11299646 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6SMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932976-B2 | Preparation of catalyst for bisphenols production | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| EP-2158040-B1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES INC (US) | 2011-02-16 | — | — | EP | disclosed |
| US-20100152028-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES LLC | 2010-06-17 | — | — | US | disclosed |
| EP-2158040-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | Dow Global Technologies Inc. (US) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008157025-A1 | PREPARATION OF CATALYST FOR BISPHENOLS PRODUCTION | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| US-6995294-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | disclosed |
| US-6992228-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2006-01-31 | — | — | US | disclosed |
| US-20050090697-A1 | Method for producing bisphenol catalysts and bisphenols | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2005-04-28 | — | — | US | disclosed |
| US-20050090696-A1 | Method for producing bisphenol catalysts and bisphenols | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2005-04-28 | — | — | US | disclosed |
| US-6884894-B2 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2005-04-26 | — | — | US | disclosed |
| US-6872860-B1 | Method for producing bisphenol catalysts and bisphenols | GENERAL ELECTRIC COMPANY (US) | 2005-03-29 | — | — | US | disclosed |
| US-6620939-B2 | Reacting phenol and acetone in the presence of acid catalysts or promoters such as 2-(3'-tert-butylthiopropylthioethyl)-pyridine on catalyst supports, to form isopropylidenediphenol; stereospecific | GENERAL ELECTRIC COMPANY | 2003-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090697-A1 | Method for producing bisphenol catalysts and bisphenols | GSTP1, PCBP1, GSTA2 | CYP1A2 533/4885CYP2D6 666/4885SMN1; SMN2 4663/4885 |
| US-20050090696-A1 | Method for producing bisphenol catalysts and bisphenols | GSTP1, PCBP1, GSTA2 | CYP1A2 533/4885CYP2D6 666/4885SMN1; SMN2 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.